Yuli Huang

3.0k total citations · 1 hit paper
67 papers, 2.0k citations indexed

About

Yuli Huang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Yuli Huang has authored 67 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Yuli Huang's work include Blood Pressure and Hypertension Studies (8 papers), Nutritional Studies and Diet (7 papers) and Diet and metabolism studies (6 papers). Yuli Huang is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Nutritional Studies and Diet (7 papers) and Diet and metabolism studies (6 papers). Yuli Huang collaborates with scholars based in China, Australia and United States. Yuli Huang's co-authors include Anqing Huang, Haoxiao Zheng, Zhiye Wu, Minsheng Chen, Xiaoyan Cai, Weiyi Mai, Dingli Xu, Peisong Chen, Hailan Zhu and Hongfeng Tang and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Yuli Huang

62 papers receiving 2.0k citations

Hit Papers

Circular RNA-protein interactions: functions, mechanisms,... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuli Huang China 21 1.0k 625 490 238 233 67 2.0k
Pengcheng He China 22 757 0.7× 333 0.5× 346 0.7× 75 0.3× 250 1.1× 161 1.9k
Dong Cheol Han South Korea 20 831 0.8× 169 0.3× 237 0.5× 239 1.0× 255 1.1× 52 2.0k
Lucía Mercedes Mauro United States 20 1.4k 1.4× 402 0.6× 511 1.0× 58 0.2× 141 0.6× 44 2.7k
Siegfried Weger Austria 16 1.5k 1.5× 1.3k 2.0× 353 0.7× 130 0.5× 385 1.7× 18 3.0k
Ion S. Jovin United States 21 618 0.6× 386 0.6× 722 1.5× 138 0.6× 438 1.9× 79 2.5k
Caroline Schmidt‐Lucke Germany 15 819 0.8× 216 0.3× 729 1.5× 98 0.4× 461 2.0× 36 1.9k
Zbigniew Gaciong Poland 19 831 0.8× 168 0.3× 324 0.7× 105 0.4× 250 1.1× 108 1.9k
Stefan Verlohren Germany 36 300 0.3× 277 0.4× 703 1.4× 100 0.4× 352 1.5× 103 5.6k
Yi-An Ko United States 17 1.1k 1.0× 228 0.4× 140 0.3× 173 0.7× 312 1.3× 32 2.4k
Shengshou Hu China 18 629 0.6× 180 0.3× 367 0.7× 84 0.4× 365 1.6× 62 1.7k

Countries citing papers authored by Yuli Huang

Since Specialization
Citations

This map shows the geographic impact of Yuli Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuli Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuli Huang more than expected).

Fields of papers citing papers by Yuli Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuli Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuli Huang. The network helps show where Yuli Huang may publish in the future.

Co-authorship network of co-authors of Yuli Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuli Huang. A scholar is included among the top collaborators of Yuli Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuli Huang. Yuli Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zhi‐Jie, Lingxiao Li, Hao Zhang, et al.. (2025). Multimodal mechanisms of di (2-ethylhexyl) phthalate-induced cardiovascular-kidney-metabolic syndrome: Integrating epidemiology, network toxicology and experimental validation. Ecotoxicology and Environmental Safety. 309. 119515–119515. 1 indexed citations
2.
Huang, Yuli, Ke Yang, Jing Yang, et al.. (2025). Redirecting On‐surface Cycloaddition Reactions in a Self‐assembled Ordered Molecular Array on Graphite. Angewandte Chemie International Edition. 64(16). e202425185–e202425185. 1 indexed citations
3.
Huang, Yuli, et al.. (2025). Emodin Promotes Peripheral Nerve Repair by Modulating Inflammasome Activation Through Autophagy via the EGFR/PI3K/AKT/mTOR Pathway. Phytotherapy Research. 39(5). 2324–2338. 4 indexed citations
5.
Li, Shuhuan, et al.. (2024). Prognostic value of red blood cell distribution width-to-albumin ratio in ICU patients with coronary heart disease and diabetes mellitus. Frontiers in Endocrinology. 15. 1359345–1359345. 12 indexed citations
6.
Cai, Xiaoyan, Xiong Liu, Lichang Sun, et al.. (2021). Prediabetes and the risk of heart failure: A meta‐analysis. Diabetes Obesity and Metabolism. 23(8). 1746–1753. 109 indexed citations
7.
Yang, Yanhua, Suxia Guo, Chunhua Deng, et al.. (2020). Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation. Cardiology Research and Practice. 2020. 1–7. 8 indexed citations
8.
Huang, Anqing, Hailan Zhu, Xinyue Liu, et al.. (2020). Gut microbiota‐derived trimethylamine N ‐oxide is associated with poor prognosis in patients with heart failure. The Medical Journal of Australia. 213(8). 374–379. 65 indexed citations
9.
Zhou, Zien, Brendon L. Neuen, Jie Yu, et al.. (2020). Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 23(1). 252–257. 18 indexed citations
10.
Wu, Jiandi, Haoxiao Zheng, Xinyue Liu, et al.. (2020). Prognostic Value of Secreted Frizzled-Related Protein 5 in Heart Failure Patients With and Without Type 2 Diabetes Mellitus. Circulation Heart Failure. 13(9). e007054–e007054. 44 indexed citations
11.
Zhu, Hailan, Haoxiao Zheng, Xinyue Liu, Weiyi Mai, & Yuli Huang. (2020). Clinical applications for out-of-office blood pressure monitoring. Therapeutic Advances in Chronic Disease. 11. 1754193436–1754193436. 15 indexed citations
12.
Yang, Shaomin, et al.. (2020). Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure. Oxidative Medicine and Cellular Longevity. 2020. 1–9. 22 indexed citations
13.
Huang, Anqing & Yuli Huang. (2020). Role of Sfrps in cardiovascular disease. Therapeutic Advances in Chronic Disease. 11. 1754193766–1754193766. 31 indexed citations
14.
Liu, Xinyue, Haoxiao Zheng, Xiaohui Huang, et al.. (2020). IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway. Stem Cell Research & Therapy. 11(1). 22–22. 78 indexed citations
15.
Liu, Xinyue, Haoxiao Zheng, Hailan Zhu, et al.. (2020). Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease. International Journal of Biological Sciences. 16(5). 730–738. 35 indexed citations
16.
Mai, Linlin, Xinyue Liu, Hailan Zhu, et al.. (2019). A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation. BMJ Open. 9(9). e031180–e031180. 8 indexed citations
17.
Liu, Deping, et al.. (2019). Lipoprotein-Associated Phospholipase A2 Activity and Mass as Independent Risk Factor of Stroke: A Meta-Analysis. BioMed Research International. 2019. 1–11. 18 indexed citations
18.
Huang, Yuli, et al.. (2018). Gamma-Glutamyltransferase and Risk of Acute Coronary Syndrome in Young Chinese Patients: A Case-Control Study. Disease Markers. 2018. 1–6. 11 indexed citations
19.
Huang, Yuli, et al.. (2017). Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients. Disease Markers. 2017. 1–6. 5 indexed citations
20.
Huang, Yuli, Yi Luo, Dingji Zhu, et al.. (2014). Increased serum 2-oxoglutarate associated with high myocardial energy expenditure and poor prognosis in chronic heart failure patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(11). 2120–2125. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026